New study expands evaluation of gene therapy for spinal muscular atrophy ...Middle East

The rarity of spinal muscular atrophy (SMA) means that promising new treatments may be tested in only a limited spectrum of patients before approval. Investigators evaluated a newly approved drug, onasemnogene abeparvovec, in a broader spectrum of patients in order to obtain expanded data on its side effects profile.

Hence then, the article about new study expands evaluation of gene therapy for spinal muscular atrophy was published today ( Tuesday 06/04/2021 - 06:49 PM ) and is available on ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( New study expands evaluation of gene therapy for spinal muscular atrophy )

Also on site :

• Scammer posed as ‘well-known adult film star’ to defraud NFL and NBA players online from behind bars, feds say
• Video: What we know about Israel’s assault on southern Lebanon
• Sarah Michelle Gellar reveals who’s to blame for ‘Buffy’ reboot cancellation